Novel Role of Peroxisome Proliferator Activated Receptor Beta/Delta in X-Linked Adrenoleukodystrophy

过氧化物酶体增殖物激活受体β/δ在X连锁肾上腺脑白质营养不良中的新作用

基本信息

项目摘要

Project Summary/Abstract Adrenoleukodystrophy (ALD) is a hereditary metabolic disorder that manifests with inflammatory degeneration of the brain and progressive spinal cord atrophy. ALD is characterized by an accumulation of very long chain fatty acids (VLCFA) that are usually restricted to small amounts in healthy tissue. The buildup of VLCFAs contributes to the development of oxidative stress injury, disrupted mitochondrial homeostasis, and other stressors that culminate in the loss of brain myelin, the fatty sheath that insulates nerve fibers, and robust neuroinflammation that altogether precipitate the deterioration of the major fiber tracts within the central nervous system (CNS). Despite early detection via newborn screening, only a small fraction of patients enjoys a therapeutic option in bone marrow transplantation, which is the sole approved therapy for ALD. For the majority of patients, however, bone marrow transplantation is ineffective, particularly for the spinal cord atrophy phenotype which has near complete penetrance. Approaches to broaden therapeutic options are critical then, and especially relevant is the discovery of molecular targets and pathways that can help reverse the disease processes. We found that one candidate target is the nuclear receptor called peroxisome proliferator activated receptor beta/delta (Pparβ/δ), which serves as a regulator for various lipid metabolic pathways in the brain cell- type that produces myelin and is critical for myelin maintenance. We have observed that genes regulated by Pparβ/δ encode key components necessary for VLCFA metabolism, which when upregulated can compensate for the VLCFA oxidation defect observed in ALD. In this proposal, we will work to elucidate the role of Pparβ/δ in the context of ALD, with the aims of determining the mechanism by which Pparβ/δ can mitigate the accumulation of VLCFAs in disease relevant tissues. Additionally, this project will reveal novel molecular pathways underlying the pathomechanism of ALD, which will amplify pursuable therapeutic targets, as well as decipher how disruptions in the immune compartment can aggravate disease progression. To accomplish these aims, the project will employ genetically engineered mice and various primary cell culture systems as model systems for ALD, along with an assortment of well-established methods and rigorously designed experimental approaches. In sum, this comprehensive study will help delineate a targetable molecular pathway with therapeutic potential for ALD, as well as describe additional molecular pathways pertinent to disease onset and progression. Additionally, this project will also provide the PI with a substantial training and learning experience to facilitate the development into a skilled and innovative physician scientist.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Alexander Barnes其他文献

Joseph Alexander Barnes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Alexander Barnes', 18)}}的其他基金

Novel Role of Peroxisome Proliferator Activated Receptor Beta/Delta in X-Linked Adrenoleukodystrophy
过氧化物酶体增殖物激活受体β/δ在X连锁肾上腺脑白质营养不良中的新作用
  • 批准号:
    10477980
  • 财政年份:
    2022
  • 资助金额:
    $ 3.35万
  • 项目类别:

相似海外基金

Role of peroxisome-mitochondrion communication in tissue aging
过氧化物酶体-线粒体通讯在组织衰老中的作用
  • 批准号:
    10736217
  • 财政年份:
    2023
  • 资助金额:
    $ 3.35万
  • 项目类别:
Determining the Role of p97 Adaptor UBXD8 in Peroxisome Function
确定 p97 适配器​​ UBXD8 在过氧化物酶体功能中的作用
  • 批准号:
    10534586
  • 财政年份:
    2022
  • 资助金额:
    $ 3.35万
  • 项目类别:
Novel Role of Peroxisome Proliferator Activated Receptor Beta/Delta in X-Linked Adrenoleukodystrophy
过氧化物酶体增殖物激活受体β/δ在X连锁肾上腺脑白质营养不良中的新作用
  • 批准号:
    10477980
  • 财政年份:
    2022
  • 资助金额:
    $ 3.35万
  • 项目类别:
The role of peroxisome proliferator-activated receptor alpha in the thermal tolerance and adaptive potential of fish
过氧化物酶体增殖物激活受体α在鱼类耐热性和适应潜力中的作用
  • 批准号:
    575232-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 3.35万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Pathogenic role of peroxisome proliferator-activated receptor alpha in periodontitis
过氧化物酶体增殖物激活受体α在牙周炎中的致病作用
  • 批准号:
    10363668
  • 财政年份:
    2021
  • 资助金额:
    $ 3.35万
  • 项目类别:
Role of peroxisome proliferation in leptin resistance
过氧化物酶体增殖在瘦素抵抗中的作用
  • 批准号:
    10320591
  • 财政年份:
    2020
  • 资助金额:
    $ 3.35万
  • 项目类别:
The investigation of peroxisome proliferator-activated receptor gamma and its role in emotional memory processing
过氧化物酶体增殖物激活受体γ及其在情绪记忆加工中的作用研究
  • 批准号:
    535407-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 3.35万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Determining the role of peroxisome contact in maintaining mitochondrial health
确定过氧化物酶体接触在维持线粒体健康中的作用
  • 批准号:
    404180
  • 财政年份:
    2018
  • 资助金额:
    $ 3.35万
  • 项目类别:
    Studentship Programs
The Role of Peroxisome Proliferator Activated Receptor Alpha in Autosomal Dominant Polycystic Kidney Disease
过氧化物酶体增殖物激活受体α在常染色体显性多囊肾病中的作用
  • 批准号:
    10152648
  • 财政年份:
    2018
  • 资助金额:
    $ 3.35万
  • 项目类别:
The Role of Peroxisome Proliferator Activated Receptor Alpha in Autosomal Dominant Polycystic Kidney Disease
过氧化物酶体增殖物激活受体α在常染色体显性多囊肾病中的作用
  • 批准号:
    10397035
  • 财政年份:
    2018
  • 资助金额:
    $ 3.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了